Contract manufacturing, prevalent in industries such as pharmaceuticals, involves outsourcing production to third-party manufacturers. In the pharmaceutical sector, companies utilize contract manufacturing organizations (CMOs) to produce drugs efficiently. This approach reduces costs, enhances flexibility, and accesses specialized expertise without investing in their facilities. It also aids in meeting regulatory requirements, leveraging the CMOs' established quality control processes and certifications. Focusing on other aspects such as marketing and R&D, companies can optimize their resources while ensuring the timely delivery of high-quality products.
Global Contract Manufacturing Market will grow at a CAGR of 6.2% during the forecast period of 2023-2030.
To know more, visit https://www.databridgemarketresearch.com/jp/reports/global-contract-manufacturing-market
Below are the Top Contract Manufacturing Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
Aenova Group
|
Aenova is a leading contract manufacturer in the pharmaceutical and healthcare industries, offering a wide range of services, including development, manufacturing, and packaging. With state-of-the-art facilities and expertise in regulatory compliance, Aenova caters to both large pharmaceutical companies and small biotech startups, providing tailored solutions for drug production.
|
|
Europe
|
In April 2024, Kühne Holding acquired Aenova Group, a leading pharmaceutical contract development and manufacturing organization (CDMO), from BC Partners. Aenova achieved a record pro-forma revenue of €832m in 2023, reflecting a 17% increase from the previous year. The acquisition signifies Kühne Holding's strategic expansion into the healthcare and pharmaceutical sectors, leveraging Aenova's market-leading capabilities and innovation. This move strengthens Aenova's position as one of the top ten CDMOs globally and sets the stage for further advancements in operational excellence and customer-centric services.
|
|
2.
|
Thermo Fisher Scientific Inc.
|
Thermo Fisher is a global leader in contract manufacturing services, particularly in the life sciences and healthcare sectors. Their comprehensive capabilities span from drug substance development to packaging and distribution, enabling clients to streamline their supply chain and accelerate time-to-market for pharmaceutical products.
|
|
Europe, Asia-Pacific, South America, North America, and Middle East and Africa
|
In February 2023, Thermo Fisher Scientific, the world leader in serving science, and Celltrio, a leading manufacturer of robotics-based solutions for the life sciences industry, announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers.
|
|
3.
|
Evonik Industries AG
|
Evonik is a diversified chemicals company that offers contract manufacturing services, primarily in the areas of specialty chemicals and advanced materials. With a focus on innovation and sustainability, Evonik collaborates closely with clients to develop custom formulations and manufacturing processes to meet their specific requirements.
|
|
North America, South America, Asia-Pacific, Middle East and Africa, and Europe
|
In March 2023, Evonik Industries AG announced the opening of a new GMP facility to manufacture lipids for advanced pharmaceutical drug delivery applications. The lipid launch facility is located at the company's site in Hanau, Germany, and provides customers with quantities of lipids as needed for clinical and small-scale commercial manufacturing.
|
|
4.
|
Lonza
|
Lonza is a prominent player in the contract manufacturing market, specializing in biopharmaceuticals and cell and gene therapies. With advanced manufacturing facilities and expertise in bioprocessing, Lonza supports clients in developing and manufacturing complex biologics, helping them bring innovative therapies to patients worldwide.
|
|
Europe, Asia-Pacific, South America, North America, and Middle East and Africa
|
In November 2022, Lonza, a preferred partner to the pharmaceutical, biotech, and nutraceutical markets, launched an innovative new capsule solution for intestinal (enteric) drug delivery. The Capsugel Enprotec capsule does not disintegrate during stomach transit and only releases its contents in the intestine. Capsugel Enprotect capsules significantly simplify the drug product manufacturing process by mitigating the need for additional capsule coating or sealing.
|
|
5.
|
Boehringer Ingelheim International GmbH
|
Boehringer Ingelheim is a major pharmaceutical company that also offers contract manufacturing services to third-party clients. With a strong emphasis on quality and compliance, Boehringer Ingelheim provides end-to-end solutions for drug development and manufacturing, leveraging its extensive experience in the pharmaceutical industry.
|
|
Europe, Asia-Pacific, South America, North America, and Middle East and Africa
|
In January 2023, the U.S. FDA accepted the supplemental new drug application for Jardiance for adults with chronic kidney disease.
|
Conclusion
In the contract manufacturing market, companies such as Aenova Group, Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza, and Boehringer Ingelheim International GmbH play pivotal roles, offering specialized services across various industries. Their expertise ranges from pharmaceuticals to specialty chemicals, biopharmaceuticals, and advanced materials. These companies provide comprehensive solutions, including development, manufacturing, and packaging, enabling clients to optimize their supply chains, accelerate product development, and meet regulatory requirements. With their state-of-the-art facilities, regulatory expertise, and commitment to quality, they are instrumental in driving innovation and bringing high-quality products to markets worldwide.
